Latest Articles
The new Dyson Airstrait is finally available for purchase - Mashable
The new Dyson Airstrait is finally available for purchase Mashable
Published: Aug. 26, 2025, 10 p.m.
Best Buy's 4th of July sale: Save big on iPads, laptops, and more - Mashable
Best Buy's 4th of July sale: Save big on iPads, laptops, and more Mashable
Published: Aug. 26, 2025, 10 p.m.
Upgrade your audio system with up to 38% off Sony soundbars, headphones, and more - Mashable
Upgrade your audio system with up to 38% off Sony soundbars, headphones, and more Mashable
Published: Aug. 26, 2025, 10 p.m.
Advanced Fellowship in Minimally Invasive Gynecological Surgery (AF MIGS) - VA.gov Home | Veterans Affairs
Advanced Fellowship in Minimally Invasive Gynecological Surgery (AF MIGS) VA.gov Home | Veterans Affairs
Published: Aug. 26, 2025, 9:45 p.m.
Top Reasons to Buy AXOL(axol) - Trade Entry Summary & Weekly Setup with ROI Potential - Newser
Top Reasons to Buy AXOL(axol) - Trade Entry Summary & Weekly Setup with ROI Potential Newser
Published: Aug. 26, 2025, 8:36 p.m.
Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches - Frontiers
Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches Frontiers
Published: Aug. 26, 2025, 3:55 p.m.
Can Bladder Endometriosis Be Hard to Diagnose? A two-case report and literature review - Frontiers
Can Bladder Endometriosis Be Hard to Diagnose? A two-case report and literature review Frontiers
Published: Aug. 26, 2025, 3:33 p.m.
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? - MSN
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? MSN
Published: Aug. 26, 2025, 12:50 p.m.
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? - Business Today
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? Business Today
Published: Aug. 26, 2025, 12:29 p.m.
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial - Nature
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial Nature
Published: Aug. 26, 2025, 11:43 a.m.
Link copied to clipboard!